Enzo Biochem (NYSE:ENZ) Now Covered by Analysts at StockNews.com

StockNews.com started coverage on shares of Enzo Biochem (NYSE:ENZ) in a research note published on Thursday. The firm issued a hold rating on the medical research company’s stock.

Enzo Biochem Stock Performance

Shares of Enzo Biochem stock opened at $0.49 on Thursday. Enzo Biochem has a 1 year low of $0.41 and a 1 year high of $1.38. The company’s fifty day simple moving average is $0.63 and its 200-day simple moving average is $0.93.

Enzo Biochem (NYSE:ENZ) last posted its quarterly earnings results on Monday, December 16th. The medical research company reported ($0.05) earnings per share for the quarter. Enzo Biochem had a negative return on equity of 7.96% and a negative net margin of 75.34%.

Institutional Investors Weigh In On Enzo Biochem

A number of institutional investors have recently bought and sold shares of ENZ. Mink Brook Asset Management LLC acquired a new stake in Enzo Biochem during the fourth quarter worth $577,000. Lepercq Multi Asset Fund bought a new position in shares of Enzo Biochem during the fourth quarter valued at $88,000. BBR Partners LLC bought a new position in shares of Enzo Biochem during the third quarter valued at $112,000. Wittenberg Investment Management Inc. lifted its holdings in shares of Enzo Biochem by 60.1% during the fourth quarter. Wittenberg Investment Management Inc. now owns 187,537 shares of the medical research company’s stock valued at $134,000 after acquiring an additional 70,400 shares during the period. Finally, Virtu Financial LLC bought a new position in shares of Enzo Biochem during the fourth quarter valued at $35,000. Institutional investors and hedge funds own 36.90% of the company’s stock.

Enzo Biochem Company Profile

Enzo Biochem, Inc develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis.